Bayer wins US approval for new birth control pill


May 6, 2010

The U.S. Food and Drug Administration said on Thursday it approved Bayer AG’s new birth control pill Natazia.

The pill, already licensed in Europe under the brand name Qlaira, is the first four-phase oral contraceptive marketed in the United States, the FDA said.

It delivers varying doses of the hormones progestin at four times throughout each 28-day treatment cycle.

“Nearly 12 million women in the United States and more than 100 million women worldwide currently use oral contraceptives,” said the FDA’s Dr. Scott Monroe.

“The approval of Natazia provides another option for women who choose to use an oral contraceptive as their method of contraception.”

Two studies of 1,867 women found Natazia was effective, with many of the same side effects as other birth control pills, the FDA said.

In October, Bayer reported the drug could also reduce excessive menstrual bleeding.


Another experiment – with another hook – decreases excessive menstrual bleeding… is called marketing, folks…whether or not the pill does decrease bleeding – the same thing can be done naturally….

Read all of the articles that I have been posting about the dangers of BCP’s. Remember girls using BCP’s must still use another from of birth control¬† protection to protect against STD’s.


Author: Leslie Carol Botha

Author, publisher, radio talk show host and internationally recognized expert on women's hormone cycles. Social/political activist on Gardasil the HPV vaccine for adolescent girls. Co-author of "Understanding Your Mood, Mind and Hormone Cycle." Honorary advisory board member for the Foundation for the Study of Cycles and member of the Society for Menstrual Cycle Research.